Recent Finacing
Recent Raise
Alpha-9 Theranostics develops peptide- and small-molecule–modified radiopharmaceutical imaging and therapeutic agents to selectively deliver radiation to solid and hematologic tumors, advancing multiple programs toward clinical trials.
